Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 01, 2006 (Vol. 26, No. 3)

Biolink USA Ireland

  • News
  • Dull, too little information
Here's a URL a bit in a search for its identity. Alternatively, I may just be too dense to perceive it but I don't think so. With the name Biolink in its title, the site would seem to be about links between the U.S. and Ireland relating to some aspect of biology. It sort of has this in the form of news articles posted monthly on the site that are actually links to news on other sites. That seems to be about the extent of the linking. Other aspects of the site include two bloggers (snore) talking about life in Texas or Ireland. While the stated aims of the site are to foster a sense of community between the Ireland Irish and the U.S. Irish in biotechnology, the whole thing just doesn't seem to work very well. Perhaps a greater focus on news would help.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »